Reuters logo
BRIEF-Medtronic initiates global trial evaluating cryoablation to treat persistent atrial fibrillation
March 30, 2017 / 2:07 PM / 6 months ago

BRIEF-Medtronic initiates global trial evaluating cryoablation to treat persistent atrial fibrillation

March 30 (Reuters) - Medtronic Plc:

* Medtronic initiates global trial evaluating cryoablation to treat persistent atrial fibrillation

* STOP Persistent AF is a prospective, multicenter, single-arm clinical trial that will enroll up to 225 patients at 25 centers Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below